Ignite Creation Date:
2024-05-05 @ 11:44 PM
Last Modification Date:
2024-10-26 @ 10:38 AM
Study NCT ID:
NCT01406470
Status:
COMPLETED
Last Update Posted:
2014-01-10
First Post:
2011-07-26
Brief Title:
Phase 3 Study of Immune Globulin Intravenous HumanIVIG-SN in Subjects With Primary Immunodeficiency
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-26
First Submit QC Date:
July 29 2011
Study First Post Date:
2011-08-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-09
Last Update Post Date:
2014-01-10
Last Update Post Date Type:
ESTIMATED